Compare Bio Protocol (BIO) vs Cudis (CUDIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Cudis — how do they compare? Bio Protocol trades at Rp442.37 (market cap Rp1T, Rp162,69M 24h volume), while Cudis trades at Rp19.41 (market cap Rp4,8M, Rp9,48M 24h volume). The key difference: Bio Protocol is far larger — about 208333.3× Cudis's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 247,5M / 1B CUDIS (25%) for Cudis. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Cudis for 11 Days on average.
| BIO | CUDIS | |
|---|---|---|
Market Cap | Rp1T | Rp4,8M |
Volume (24h) | Rp162,69M | Rp9,48M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 247,5M / 1B CUDIS (25%) |
Typical Hold Time | 18 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Cudis is trading at Rp19.346 with a market cap of Rp4.78M, showing bearish technical signals with 13 sell signals in moving averages. The token has limited circulation at 25% of max supply and short average hold time of 11 days. Current price sits near key support levels with RSI indicators suggesting potential oversold conditions. No recent protocol updates or ecosystem developments were identified.
Overall outlook remains cautious due to strong bearish technical signals and limited market depth. Key opportunity lies in potential oversold bounce from support levels, while major risks include low liquidity, high volatility, and the token's early adoption stage. Investors should monitor for increased trading volume and network activity.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Cudis
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →
